My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Ars Pharmaceutica (Internet)
On-line version ISSN 2340-9894
Abstract
TORRALBA FERNANDEZ, Laura and AMADOR FERNANDEZ, Noelia. Development of a medication review with follow-up guide on patients with epilepsy. Ars Pharm [online]. 2019, vol.60, n.1, pp.35-40. Epub Mar 28, 2019. ISSN 2340-9894. https://dx.doi.org/10.30827/ars.v60i1.8219.
Aim:
Prepare a document to conduct medication review with follow-up of patients diagnosed with epilepsy. This document is been addressed to every health professional who take care of the patient, especially to community pharmacists.
Method:
A literature review has been performed over the available resources until 15 June 2017. The search strategy considers sources of evidence in epilepsy, pharmaceutical care and medication review with follow-up guides, human pharmacology and dispensing books, drugs databases and scientific evidence databases.
Results: In the application of the medication review with follow-up of patients with epilepsy, the treatment should be assessed through indicators of necessity (existence of a health problem that justifies the use of anticonvulsants), effectiveness (absence or decrease of the number of epileptic seizures) and safety (absence of adverse reactions, contraindications and interactions). This allows the appropriate co-design of an intervention strategy in collaboration with the patient and/or other health-care providers to improve the patients’ quality of life.
Conclusions:
This guide includes detailed information about the epilepsy and the treatments used by considering the patient as a unit and not divided according to their health problems. Therefore, this guide could be a useful tool tailored to those pharmacists involved in the medication review with follow-up of patients with epilepsy.
Keywords : epilepsy; anticonvulsants; pharmaceutical services; medication review with follow-up.